消息
×
loading..
Structural basis for signal recognition and transduction by platelet-activating-factor receptor
2018-06
发表期刊NATURE STRUCTURAL & MOLECULAR BIOLOGY (IF:12.5[JCR-2023],13.1[5-Year])
ISSN1545-9993
卷号25期号:6页码:488-+
发表状态已发表
DOI10.1038/s41594-018-0068-y
摘要Platelet-activating-factor receptor (PAFR) responds to platelet-activating factor (PAF), a phospholipid mediator of cell-to-cell communication that exhibits diverse physiological effects. PAFR is considered an important drug target for treating asthma, inflammation and cardiovascular diseases. Here we report crystal structures of human PAFR in complex with the antagonist SR 27417 and the inverse agonist ABT-491 at 2.8-A and 2.9-A resolution, respectively. The structures, supported by molecular docking of PAF, provide insights into the signal-recognition mechanisms of PAFR. The PAFR-SR 27417 structure reveals an unusual conformation showing that the intracellular tips of helices II and IV shift outward by 13A and 44, respectively, and helix VIII adopts an inward conformation. The PAFR structures, combined with single-molecule FRET and cell-based functional assays, suggest that the conformational change in the helical bundle is ligand dependent and plays a critical role in PAFR activation, thus greatly extending knowledge about signaling by G-protein-coupled receptors.
收录类别SCI ; SCIE
语种英语
资助项目Program of Introducing Talents of Discipline to the Universities of the Ministry of Education[B08029]
WOS研究方向Biochemistry & Molecular Biology ; Biophysics ; Cell Biology
WOS类目Biochemistry & Molecular Biology ; Biophysics ; Cell Biology
WOS记录号WOS:000434470800009
出版者NATURE PUBLISHING GROUP
WOS关键词PROTEIN-COUPLED-RECEPTOR ; CRYO-EM STRUCTURE ; HUMAN P2Y(12) RECEPTOR ; CRYSTAL-STRUCTURE ; FORCE-FIELD ; CONFORMATIONAL-CHANGES ; GLP-1 RECEPTOR ; HIGHLY POTENT ; COMPLEX ; ANTAGONIST
原始文献类型Article
引用统计
正在获取...
文献类型期刊论文
条目标识符https://kms.shanghaitech.edu.cn/handle/2MSLDSTB/27439
专题iHuman研究所
iHuman研究所_特聘教授组_Raymond Stevens组
生命科学与技术学院_特聘教授组_吴蓓丽组
通讯作者Zhang, Xuejun C.; Wu, Beili
作者单位
1.Chinese Acad Sci, Natl Ctr Prot Sci Beijing, Inst Biophys, Natl Lab Biomacromol,CAS Ctr Excellence Biomacrom, Beijing, Peoples R China
2.Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai, Peoples R China
3.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China
4.Univ Chinese Acad Sci, Beijing, Peoples R China
5.Huazhong Univ Sci & Technol, Minist Educ, Coll Life Sci & Technol, Collaborat Innovat Ctr Genet & Dev, Wuhan, Hubei, Peoples R China
6.Huazhong Univ Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan, Hubei, Peoples R China
7.Zhengzhou Univ, Sch Basic Med Sci, Dept Pharmacol, Zhengzhou, Henan, Peoples R China
8.Univ Southern Calif, Dept Chem, Bridge Inst, Los Angeles, CA USA
9.Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai, Peoples R China
10.ShanghaiTech Univ, iHuman Inst, Shanghai, Peoples R China
11.ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China
12.Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Beijing, Peoples R China
通讯作者单位生命科学与技术学院
推荐引用方式
GB/T 7714
Cao, Can,Tan, Qiuxiang,Xu, Chanjuan,et al. Structural basis for signal recognition and transduction by platelet-activating-factor receptor[J]. NATURE STRUCTURAL & MOLECULAR BIOLOGY,2018,25(6):488-+.
APA Cao, Can.,Tan, Qiuxiang.,Xu, Chanjuan.,He, Lingli.,Yang, Linlin.,...&Wu, Beili.(2018).Structural basis for signal recognition and transduction by platelet-activating-factor receptor.NATURE STRUCTURAL & MOLECULAR BIOLOGY,25(6),488-+.
MLA Cao, Can,et al."Structural basis for signal recognition and transduction by platelet-activating-factor receptor".NATURE STRUCTURAL & MOLECULAR BIOLOGY 25.6(2018):488-+.
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Cao, Can]的文章
[Tan, Qiuxiang]的文章
[Xu, Chanjuan]的文章
百度学术
百度学术中相似的文章
[Cao, Can]的文章
[Tan, Qiuxiang]的文章
[Xu, Chanjuan]的文章
必应学术
必应学术中相似的文章
[Cao, Can]的文章
[Tan, Qiuxiang]的文章
[Xu, Chanjuan]的文章
相关权益政策
暂无数据
收藏/分享
文件名: 27439.pdf
格式: Adobe PDF
此文件暂不支持浏览
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。